Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Pseudomonas aeruginosa O-polysaccharide, also known as the O-antigen, is a key structural component of the lipopolysaccharide (LPS) found in the outer membrane of this Gram-negative bacterium. It plays a crucial role in defining serotype specificity and mediating interactions with host immune systems. There are two main types: the Common Polysaccharide Antigen (CPA/A-band) and the O-Specific Antigen (OSA/B-band). The O-polysaccharide contributes to virulence by evading immunity, facilitating colonization, and promoting biofilm formation, making it a potential target for vaccine development or antimicrobial therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa O-polysaccharide (O-PS).